Blog: I’ll be Leonardo and so much more

In a profession that values super subspecialization, combined with a society that pigeonholes physicians into corners, I often felt I didn’t fit into one job title with my varied passions and cross interests.

Vlog: Eye stroke evaluations have changed positively, reducing inappropriate outpatient or incomplete workups

On this week's episode of the NeuroOp Guru, Andy Lee, MD, and Elizabeth Fortin, MD, discuss the current status of eye stroke evaluations for CRAO.

Blog: A new era for refractive surgery in the United States: STAAR EVO ICL wins FDA approval

There’s a new alternative to LASIK in the United States. In March of 2022, the FDA approved STAAR Surgical’s EVO/EVO+ VISIAN Implantable Collamer Lens (ICL) and Toric Implantable Collamer Lens (TICL).

Blog: In honor of those who lift us

May 18, 2022

It’s been a minute, as the Baltimorean’s say, but I still remember my first day of residency. I knew next to nothing about ophthalmology but showed up smiling and eager to learn. I felt incredibly fortunate to be training at such a prestigious institution. I was awed by the distinguished faculty, and my co-residents couldn’t be any more impressive. In short, I wasn’t sure I belonged.

Blog: TAGS trial and real life applications

May 02, 2022

Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.